2-amino-3-methylimidazo(4,5-f)quinoline and Adenoma, Hepatocellular

2-amino-3-methylimidazo(4,5-f)quinoline has been researched along with Adenoma, Hepatocellular in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kamada, N; Kato, K; Masutani, M; Nakagama, H; Ogawa, K; Shirai, T; Sugimura, T; Suzuki, H; Tang, M	1

Other Studies

1 other study(ies) available for 2-amino-3-methylimidazo(4,5-f)quinoline and Adenoma, Hepatocellular

Article	Year
Parp-1 deficiency does not enhance liver carcinogenesis induced by 2-amino-3-methylimidazo[4,5-f]quinoline in mice. Cancer letters, 2006, May-08, Volume: 236, Issue:1 Topics: Adenoma, Liver Cell; Animals; Carcinogens; Carcinoma, Hepatocellular; Incidence; Liver; Liver Neoplasms, Experimental; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Quinolines; Stomach	2006

Article

Year

Parp-1 deficiency does not enhance liver carcinogenesis induced by 2-amino-3-methylimidazo[4,5-f]quinoline in mice.

Cancer letters, 2006, May-08, Volume: 236, Issue:1

Topics: Adenoma, Liver Cell; Animals; Carcinogens; Carcinoma, Hepatocellular; Incidence; Liver; Liver Neoplasms, Experimental; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Quinolines; Stomach

2006